Plasma homocysteine concentration in children with chronic renal failure

Citation
A. Merouani et al., Plasma homocysteine concentration in children with chronic renal failure, PED NEPHROL, 16(10), 2001, pp. 805-811
Citations number
29
Categorie Soggetti
Pediatrics
Journal title
PEDIATRIC NEPHROLOGY
ISSN journal
0931041X → ACNP
Volume
16
Issue
10
Year of publication
2001
Pages
805 - 811
Database
ISI
SICI code
0931-041X(200110)16:10<805:PHCICW>2.0.ZU;2-9
Abstract
Hyperhomocysteinemia, a risk factor for vascular disease, is commonly found in adult patients with end-stage renal disease. Major determinants of elev ated plasma homocysteine levels in these patients include deficiencies in f olate and vitamin B-12, methylenetetrahydrofolate reductase (MTHFR) genotyp e and renal function. Little information is available for children with chr onic renal failure (CRF). The prevalence and the factors that affect plasma homocysteine concentration were determined in children. Twenty-nine childr en with various degrees of CRF (15 were dialyzed, 14 were not dialyzed) wer e compared with 57 age- and sex-matched healthy children. Homocysteine conc entrations were higher in patients than controls (17.3 mu mol/l vs 6.8 mu m ol/l, P<0.0001) and hyperhomocysteinemia (>95th percentile for controls: 14 .0 mu mol/l) was seen in 62.0% of patients and 5.2% of controls. Folate con centrations were lower in patients (9.9 nmol/l) than controls (13.5 nmol/l) , P<0.01. Vitamin B-12 was similar in patients (322 pmol/l) and controls (2 84 pmol/l). Dialyzed patients have a higher prevalence of hyperhomocysteine mia than nondialyzed patients (87% vs 35%). Dialyzed patients with MTHFR mu tation have higher plasma homocysteine (28.5 <mu>mol/l) than nondialyzed pa tients with the mutation (10.7 mu mol/l), P<0.002. In our study, difference s between controls and patients in plasma homocysteine concentrations are o bserved when age is greater then 92 months, folate less than 21.6 nmol/l an d vitamin B-12 less than 522 pmol/l. Our study shows that hyperhomocysteine mia is common in children with CRF and is associated with low folate and no rmal vitamin B-12 status, compared to normal children. Among the patients, the dialyzed patients with the MTHFR mutation are particularly at risk for hyperhomocysteinemia. Further studies are needed to investigate therapeutic interventions and the potential link with vascular complications in these patients.